Leslie Oleksowicz

1.1k total citations
35 papers, 780 citations indexed

About

Leslie Oleksowicz is a scholar working on Hematology, Oncology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Leslie Oleksowicz has authored 35 papers receiving a total of 780 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Hematology, 14 papers in Oncology and 7 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Leslie Oleksowicz's work include Platelet Disorders and Treatments (13 papers), Blood groups and transfusion (4 papers) and Cell Adhesion Molecules Research (4 papers). Leslie Oleksowicz is often cited by papers focused on Platelet Disorders and Treatments (13 papers), Blood groups and transfusion (4 papers) and Cell Adhesion Molecules Research (4 papers). Leslie Oleksowicz collaborates with scholars based in United States, United Kingdom and Australia. Leslie Oleksowicz's co-authors include Janice P. Dutcher, Niyati Bhagwati, Elena Puszkin, Howard W. Bruckner, Randi Isaacs, Edward L. Schwartz, Lisa J. Cardo, Polly R. Etkind, Zhongyun Dong and Linda Levin and has published in prestigious journals such as Cancer, Cancer Research and Annals of Neurology.

In The Last Decade

Leslie Oleksowicz

35 papers receiving 752 citations

Peers

Leslie Oleksowicz

HEMAT

ONCOL

IMMUN

MB

CCM

Maria Rossikhina United States

Harumi Y. Mukai Japan

Toshiaki Shirai Japan

Sandra Cauwenberghs Netherlands

Adam Corken United States

Annachiara Mitrugno United States

Moritz Stolla United States

H. Karel Nieuwenhuis Netherlands

Ginette Schiby Israel

Yair Herishanu Israel

Maria Rossikhina United States

Leslie Oleksowicz

294 ×1.0

HEMAT

167 ×0.7

ONCOL

253 ×1.3

IMMUN

161 ×1.2

MB

165 ×1.7

CCM

Citations per year, relative to Leslie Oleksowicz Leslie Oleksowicz (= 1×) peers Maria Rossikhina

Countries citing papers authored by Leslie Oleksowicz

Since Specialization

Citations

This map shows the geographic impact of Leslie Oleksowicz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Leslie Oleksowicz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Leslie Oleksowicz more than expected).

Fields of papers citing papers by Leslie Oleksowicz

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Leslie Oleksowicz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Leslie Oleksowicz. The network helps show where Leslie Oleksowicz may publish in the future.

Co-authorship network of co-authors of Leslie Oleksowicz

This figure shows the co-authorship network connecting the top 25 collaborators of Leslie Oleksowicz. A scholar is included among the top collaborators of Leslie Oleksowicz based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Leslie Oleksowicz. Leslie Oleksowicz is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

1.

Oleksowicz, Leslie, Yin Liu, R. Bruce Bracken, et al.. (2011). Secretory phospholipase A2‐IIa is a target gene of the HER/HER2‐elicited pathway and a potential plasma biomarker for poor prognosis of prostate cancer. The Prostate. 72(10). 1140–1149. 28 indexed citations

2.

Oleksowicz, Leslie, et al.. (2000). Sustained Ventricular Tachycardia and Its Successful Prophylaxis During High-Dose Bolus Interleukin-2 Therapy for Metastatic Renal Cell Carcinoma. American Journal of Clinical Oncology. 23(1). 34–36. 1 indexed citations

3.

Oleksowicz, Leslie & Janice P. Dutcher. (1999). A phase II trial of dose-intensive interleukin-2 in metastatic renal cell carcinoma. Journal of Cancer Research and Clinical Oncology. 125(2). 101–108. 8 indexed citations

4.

Dutcher, Janice P., et al.. (1998). Acquired glanzmann's thrombasthenia associated with hodgkin's lymphoma. Cancer. 82(9). 1764–1768. 23 indexed citations

5.

Oleksowicz, Leslie, et al.. (1997). Human breast carcinoma cells synthesize a protein immunorelated to platelet glycoprotein-lbα with different functional properties. Journal of Laboratory and Clinical Medicine. 129(3). 337–346. 27 indexed citations

6.

Oleksowicz, Leslie, et al.. (1997). Apyrase, Ascorbic Acid and Aprotinin Ameliorate the Storage Lesion in Pelleted Platelet Preparations. Biotechnic & Histochemistry. 72(5). 259–267. 2 indexed citations

7.

Novik, Yelena, Leslie Oleksowicz, & Peter H. Wiernik. (1997). Therapeutic effect of cyclosporine A in thrombocytopenia after myeloablative chemotherapy in acute myeloid leukaemia. Medical Oncology. 14(1). 43–46. 2 indexed citations

8.

Oleksowicz, Leslie, et al.. (1997). Leukocytoclastic Vasculitis Associated with Nizatidine Therapy. The American Journal of Medicine. 102(2). 216–218. 6 indexed citations

9.

Oleksowicz, Leslie, et al.. (1997). A GPIbα-Related Protein Is Expressed by Fresh Human Breast Carcinoma Tissue and Is Regulated by a PKC-Sensitive Mechanism☆. Experimental Cell Research. 237(1). 110–117. 10 indexed citations

10.

Oleksowicz, Leslie, et al.. (1996). Atypical clonal T-cell proliferation in infectious mononucleosis. Medical Oncology. 13(4). 207–213. 24 indexed citations

11.

Oleksowicz, Leslie, et al.. (1996). Alterations in Platelet Function in Patients Receiving Interleukin-6 as Cytokine Therapy. Cancer Investigation. 14(4). 307–316. 7 indexed citations

12.

Oleksowicz, Leslie, et al.. (1996). Intravenous γ‐globulin inhibits binding of anti‐GM1 to its taget antigen. Annals of Neurology. 39(1). 136–139. 42 indexed citations

13.

Weiss, Geoffrey R., Kim Margolin, Mario Sznol, et al.. (1995). A Phase II Study of the Continuous Intravenous Infusion of Interleukin-6 for Metastatic Renal Cell Carcinoma. Journal of Immunotherapy. 18(1). 52–56. 13 indexed citations

14.

Oleksowicz, Leslie & Janice P. Dutcher. (1994). A REVIEW OF THE NEW CYTOKINES. American Journal of Therapeutics. 1(2). 107–115. 19 indexed citations

15.

Oleksowicz, Leslie, et al.. (1994). Effects of interleukin‐2 administration on platelet function in cancer patients. American Journal of Hematology. 45(3). 224–231. 16 indexed citations

16.

Oleksowicz, Leslie, et al.. (1994). Interleukins in Cancer Therapy. Clinical Immunotherapeutics. 1(4). 271–281. 4 indexed citations

17.

Oleksowicz, Leslie, et al.. (1991). Alterations of Platelet Function Induced by Interleukin-2. Journal of Immunotherapy. 10(5). 363–370. 17 indexed citations

18.

Paciucci, Paolo Alberto, John Mandeli, Leslie Oleksowicz, Franco Ameglio, & James F. Holland. (1990). Thrombocytopenia during immunotherapy with interleukin-2 by constant infusion. The American Journal of Medicine. 89(3). 308–312. 31 indexed citations

19.

Oleksowicz, Leslie & Howard W. Bruckner. (1988). Prophylaxis of 5-fluorouracil-induced coronary vasospasm with calcium channel blockers. The American Journal of Medicine. 85. 750–751. 2 indexed citations

20.

Oleksowicz, Leslie & Howard W. Bruckner. (1988). Prophylaxis of 5-fluorouracil-induced coronary vasospasm with calcium channel blockers. The American Journal of Medicine. 85(5). 750–751. 45 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact